United Therapeutics Corp’s recent filing unveils that its FOUNDER, CHAIRPERSON, AND CHIE ROTHBLATT MARTINE A acquired Company’s shares for reported $1.71 million on Sep 26 ’25. In the deal valued at $428.20 per share,4,000 shares were bought.
Then, CAUSEY CHRISTOPHER sold 1,000 shares, generating $440,000 in total proceeds. Upon selling the shares at $440.00, the Director now owns 4,865 shares.
Before that, ROTHBLATT MARTINE A sold 4,000 shares. United Therapeutics Corp shares valued at $1,736,489 were divested by the Chairperson & CEO at a price of $434.12 per share. As a result of the transaction, ROTHBLATT MARTINE A now holds 130 shares, worth roughly $56245.8.
RBC Capital Mkts initiated its United Therapeutics Corp [UTHR] rating to an Outperform in a research note published on September 26, 2025; the price target was $569. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early June with a ‘”an Overweight”‘ rating. Wells Fargo also remained covering UTHR and has decreased its forecast on April 25, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. BofA Securities revised its rating on April 21, 2025. It rated UTHR as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of UTHR
On Friday, United Therapeutics Corp [NASDAQ:UTHR] saw its stock jump 1.70% to $432.66. Over the last five days, the stock has gained 3.61%. United Therapeutics Corp shares have risen nearly 20.90% since the year began. Nevertheless, the stocks have risen 22.62% over the past one year. While a 52-week high of $442.01 was reached on 09/24/25, a 52-week low of $266.98 was recorded on 04/09/25.
Levels Of Support And Resistance For UTHR Stock
The 24-hour chart illustrates a support level at 425.91, which if violated will result in even more drops to 419.16. On the upside, there is a resistance level at 436.49. A further resistance level may holdings at 440.32.
How much short interest is there in United Therapeutics Corp?
A steep rise in short interest was recorded in United Therapeutics Corp stocks on 2025-09-15, dropping by 71212.0 shares to a total of 2.78 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 2.86 million shares. There was a decline of -2.56%, which implies that there is a negative sentiment for the stock.
